Mean change in angle findings, measured by any method · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Adverse effects · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Progression of visual field loss (worsening of one or more stages, accordingto the Glaucoma Staging System‐2) (at 12 months) · participants with primary angle‐closure glaucoma
Phacoemulsification probably leads to lower progression of visual field loss (worsening of one or more stages,… compared with laser peripheral iridotomy (moderate certainty).
1 finding from 1 review
OR 0.35 [0.13, 0.91]
Studies not reported
Moderate
Mean number of antiglaucoma medications at 1‐year · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
91 participants
Low
Gonioscopic findings · participants with primary angle‐closure glaucoma
3 findings from 1 review
no estimate extracted
91 participants
Low
no estimate extracted
91 participants
Low
no estimate extracted
91 participants
Low
Visual acuity · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
91 participants
Low
Adverse effects (at 12 months) · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life measures · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Glaucoma progression at 12 months, measured by additional visual field defects · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in IOP measured in mmHg 12 months postintervention · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
32 participants
Moderate
Mean number of antiglaucoma medications at 1‐year · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
32 participants
Moderate
Mean change in IOP measured in mmHg 12 months postintervention · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Gonioscopic findings (Anterior segment optical coherence tomography parameters) (at 6 months) · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
64 participants
GRADE not reported
Visual acuity · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (at 6 months) · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life measures · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Glaucoma progression at 12 months, measured by additional visual field defects · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in IOP measured in mmHg 12 months postintervention · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
63 participants
Low
Mean number of antiglaucoma medications at 1‐year · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
63 participants
Low
Gonioscopic findings · participants with primary angle‐closure glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found